Joslin scientists report the first generation of human induced pluripotent stem cells from patients with an uncommon form of diabetes, maturity onset diabetes of the young (MODY). These cells offer a powerful resource for studying the role of genetic factors in the development of MODY and testing potential treatments.
For more details: http://www.joslin.org/news/
Joslin-Scientists-First-Human- iPSC-from-Patients-with-MODY- Diabetes.html
Induced Pluripotent is a fancy way of saying the made them form adult cells not embryonic cells. They hope they can have these stem cells become beta cells. That matter because you can't go taking beta cells out of someone with MODY who needs all they can get. But if you grow them you can study how they are vulnerable to the immune system and maybe, maybe turn off that venerability.
Of course I could be wrong. I often am, please read the link above for details from Joslin.
Speaking of Joslin, John Brooks III the CEO of Joslin will be Lorraine's and my guest on DSMA Live 'Rents on Monday. Join us.